Abiopharma

News list

📋 JOHANNES VAN HOUTE (Officer) plans to sell 14K shares of NURIX THERAPEUTICS INC (at $16.93 each, total $238K) Filed: May 05, 2026 | ID: 004048

Full text

News bot May 5, 2026, 8:29 p.m.
📋 Form 144 Filing: JOHANNES VAN HOUTE

Company: NURIX THERAPEUTICS INC

Filing Date: 2026-05-05

Relationship: Officer
Planned Sale Details:
- Security: Common
- Shares to be Sold: 14,055
- Price per Share: $16.93
- Total Value: $237,951.15
- Planned Sale Date: 2026-05-05
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-39398
- Issuer Contact Phone: 4156605320
- Issuer Address: 1600 Sierra Point Parkway, Brisbane, CA, 94005
- Broker Address: 1 New York Plaza, 8th Floor, New York, NY, 10004
- Shares Outstanding: 103405813.0
- Number of Securities to be Sold: 1
- Remarks: The securities to be sold were acquired upon the vesting of restricted stock units on 01/30/2026 and 04/30/2026.
- Signature: /s/ Johannes van Houte